Literature DB >> 31901616

Ependymal cells in the spinal cord as neuronal progenitors.

Victoria Moreno-Manzano1.   

Abstract

Ependymal cells are neural progenitors and form part of the central canal of the spinal cord. Therefore, ependymal cells could serve as a potential source of neural progenitors for regenerative medicine applications. Such applications consist of endogenous activation or exogenous transplantation, alone or in combination with pharmacological treatments, to repair spinal cord injuries. This mini review describes the main phenotypical characteristics of ependymal cells from spinal cord and the opportunities offered for spinal cord injury therapeutic application.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31901616     DOI: 10.1016/j.coph.2019.11.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  5 in total

Review 1.  Tissue-specific parameters for the design of ECM-mimetic biomaterials.

Authors:  Olivia R Tonti; Hannah Larson; Sarah N Lipp; Callan M Luetkemeyer; Megan Makam; Diego Vargas; Sean M Wilcox; Sarah Calve
Journal:  Acta Biomater       Date:  2021-04-18       Impact factor: 10.633

2.  Toll-like receptors 2 and 4 differentially regulate the self-renewal and differentiation of spinal cord neural precursor cells.

Authors:  Marina Sanchez-Petidier; Consuelo Guerri; Victoria Moreno-Manzano
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

Review 3.  Regulating Endogenous Neural Stem Cell Activation to Promote Spinal Cord Injury Repair.

Authors:  Emily A B Gilbert; Nishanth Lakshman; Kylie S K Lau; Cindi M Morshead
Journal:  Cells       Date:  2022-03-01       Impact factor: 6.600

Review 4.  Recent advances in understanding cell type transitions during dorsal neural tube development.

Authors:  Chaya Kalcheim; Dina Rekler
Journal:  Fac Rev       Date:  2022-09-27

5.  Human-Induced Neural and Mesenchymal Stem Cell Therapy Combined with a Curcumin Nanoconjugate as a Spinal Cord Injury Treatment.

Authors:  Pablo Bonilla; Joaquim Hernandez; Esther Giraldo; Miguel A González-Pérez; Ana Alastrue-Agudo; Hoda Elkhenany; María J Vicent; Xavier Navarro; Michael Edel; Victoria Moreno-Manzano
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.